F.D.A. Approves Moderna’s mRNA Flu Vaccine

The New York Times – Business:

The agency had initially refused to even review the application but reversed course after a public outcry.

This post first appeared in The New York Times – Business. Read the original article.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *